The GLP-1 drugs are the latest class to show a benefit in patients, this time with OSA, but like other tools have nontrivial side effects, cost concerns, and patient persistence issues that balance out the headline benefits. The size of the underlying patient populations, which are expected to surpass 1.3 billion globally by 2050, as well as the under penetration of CPAP treatment, which Andrew ballparks at 15% or less in many markets, reinforces the analysts argument
The clinical features of GLP-1 RA-associated BP may not always correspond to the characteristic tense blisters of classic BP, and elevated autoantibody levels can persist even as clinical symptoms improve
Work with a Functional Medicine Healthcare Provider Whether youre looking to uncover the root cause of the symptoms your experiencing, optimize your body systems, or to learn how to support longevity, our providers can work with you one-on-one to help you reach your health goals
However, if youve been taking Ozempic, you will need to wait a full week from your last dose before beginning your first dose of Mounjaro
Specific peptides can be immunomodulatory